Degenerative alterations in noradrenergic neurons of the locus coeruleus in Alzheimer's disease

Neural Regeneration Research

Volumn 8, Issue 24, 2013, Pages 2249-2255

  Liu, Li Hua ^a,b   Luo, Sai Ping ^c   Zeng, Le Ping ^a   Wang, Wei Hong ^b   Yuan, Li Ming ^b   Jian, Xiao Hong ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HUNAN NORMAL UNIVERSITY   (China)

^c Agricultural Division Four Hospital   (China)

Author keywords

Alzheimer's disease; Grants supported paper; Locus coeruleus; Neural regeneration; Neuroregeneration; Noradrenergic neuron; Presenilin 1; Senile plaques; Tyrosine hydroxylase; amyloid

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PRESENILIN 1; TYROSINE 3 MONOOXYGENASE; AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LOCUS CERULEUS; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; NORADRENERGIC NERVE; QUANTITATIVE ANALYSIS; RANDOMIZATION; STEREOLOGY; TRANSGENIC MOUSE; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; NERVE CELL NECROSIS; NORADRENERGIC NERVE CELL;

EID: 84886698711     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2013.24.004     Document Type: Article

References (33)

1. McGaugh JL, Roozendaal B. Drug enhancement of memory consolidation: historical perspective and neurobiological implications. Psychopharmacology (Berl). 2009; 202(1-3):3-14.
2. Sultana R, Robinson RA, Di Domenico F, et al. Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knockin mice model of Alzheimer disease as a function of age. J Proteomics. 2011;74(11):2430-2440.
3. Borchelt DR, Thinakaran G, Eckman CB, et al. Familial Alzheimer's diseaselinked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron. 1996; 17(5):1005-1013.
4. Price DL, Wong PC, Markowska AL, et al. The value of transgenic models for the study of Neurodegenerative disease. Ann N Y Acad Sci. 2000;920:179-191.
5. Wang H, He J, Zhang R, et al. Sensorimotor gating and memory deficits in an APP/PS1 double transgenic mouse model of Alzheimer's disease. Behav Brain Res. 2012;233(1):237-243.
6. Woo RS, Lee JH, Yu HN, et al. Expression of ErbB4 in the neurons of Alzheimer's disease brain and APP/PS1 mice, a model of Alzheimer's disease. Anat Cell Biol. 2011;44(2):116-127.
7. Stone JG, Casadesus G, Gustaw-Rothenberg K, et al. Frontiers in Alzheimer's disease therapeutics. Ther Adv Chronic Dis. 2011;2(1):9-23.
8. Funke SA, Liu H, Sehl T, et al. Identification and characterization of an aβ oligomer precipitating peptide that may be useful to explore gene therapeutic approaches to Alzheimer disease. Rejuvenation Res. 2012;15(2):144-157.
9. Huang Y, Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell. 2012;148(6):1204-1222.
10. Panza F, Frisardi V, Solfrizzi V, et al. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to taubased immunization strategies. Immunotherapy. 2012;4(2): 213-238.
11. Mann D. The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system. Mech Ageing Dev. 1983;23(1):73-94.
12. German DC, Manaye KF, White III CL, et al. Disease specific patterns of locus coeruleus cell loss. Ann Neurol. 1992;(32):667-676.
13. Feinstein DL, Heneka MT, Gavrilyuk V, et al. Noradrenergic regulation of inflammatory gene expression in brain. Neurochem Int. 2002;41(5):357-365.
14. Heneka MT, Ramanathan M, Jacobs AH, et al. Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J Neurosci. 2006;26(5):1343-1354.
15. Bouret S, Sara SJ. Network reset: a simplified overarching theory of locus coeruleus noradrenaline function. Trends Neurosci. 2005;28(11):574-582.
16. German DC, Nelson O, Liang F, et al. The PDAPP mouse model of Alzheimer's disease: locus coeruleus neuronal shrinkage. J Comp Neurol. 2005;492(4):469-476.
17. Busch C, Bohl J, Ohm TG, et al. Spatial, temporal and numeric analysis of Alzheimer changes in the nucleus coeruleus. Neurobiol Aging. 1997;18(4):401-406.
18. Dineley KT, Xia X, Bui D, et al& Accelerated plaque accumulation, associative learning deficits, and upregulation of alpha 7 nicotinic receptor protein in transgenic mice coexpressing mutant human presenilin 1 and amyloid precursor proteins. J Biol Chem. 2002; 277(25):22768-22780.
19. Dhawan G, Combs CK. Inhibition of Src kinase activity attenuates amyloid associated microgliosis in a murine model of Alzheimer's disease. J Neuroinflammation. 2012; 9:117.
20. Busche MA, Chen X, Henning HA, et al. Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A. 2012;109(22):8740-8745.
21. Poduslo JF, Howell KG, Olson NC, et al. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils. Biochemistry. 2012;51(19):3993-4003.
22. Sastre M, Klockgether T, Heneka MT. Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms. Int J Dev Neurosci. 2006;24(2-3):167-176.
23. Jardanhazi-Kurutz D, Kummer MP, Terwel D, et al. Distinct adrenergic system changes and neuroinflammation in response to induced locus ceruleus degeneration in APP/PS1 transgenic mice. Neuroscience. 2011;176:396-407.
24. Heneka MT, Galea E, Gavriluyk V, et al. Noradrenergic depletion potentiates betaamyloid-induced cortical inflammation: implications for Alzheimer's disease. J Neurosci. 2002;22(7):2434-2442.
25. Jardanhazi-Kurutz D, Kummer MP, Terwel D, et al. Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits. Neurochem Int. 2010;57(4):375-382.
26. Carnevale D, De Simone R, Minghetti L. Microglia-neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems. CNS Neurol Disord Drug Targets. 2007;6(6):388-397.
27. Morrissette DA, Parachikova A, Green KN, et al. Relevance of transgenic mouse models to human Alzheimer disease. J Biol Chem. 2009;284(10):6033-6037.
28. Marchetti C, Marie H. Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models. Rev Neurosci. 2011;22(4):373-402.
29. The Ministry of Science and Technology of the People's Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.
30. O'Neil JN, Mouton PR, Tizabi Y, et al. Catecholaminergic neuronal loss in locus coeruleus of aged female dtg APP/PS1 mice. J Chem Neuroanat. 2007;34(3-4):102-107.
31. Long JM, Kalehua AN, Muth NJ, et al. Stereological analysis of astrocyte and microglia in aging mouse hippocampus. Neurobiol Aging. 1998;19(5):497-503.
32. Kelley CM, Perez SE, Overk CR, et al. Effect of neocortical and hippocampal amyloid deposition upon galaninergic and cholinergic neurites in AβPPswe/PS1ΔE9 mice. J Alzheimers Dis. 2011;25(3):491-504.
33. Riise J, Pakkenberg B. Stereological estimation of the total number of myelinated callosal fibers in human subjects. J Anat. 2011;218(3):277-284.